Welcome to our dedicated page for NHA news (Ticker: NHA), a resource for investors and traders seeking the latest updates and insights on NHA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NHA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NHA's position in the market.
The Nuveen Municipal 2021 Target Term Fund (NYSE: NHA) has successfully completed its termination and liquidation as of March 1, 2021. The fund returned a net asset value (NAV) of $9.7100 per share to shareholders, slightly above the original NAV of $9.85. The total distribution, including a special payment made on February 12, 2021, amounted to $9.8585 per share. Over its five-year term, the fund paid regular distributions totaling $0.9359 per share, resulting in an average distribution rate of 1.86% on NAV. Shareholders may face tax implications due to the liquidation.
Nuveen has declared a special tax-exempt distribution for the Nuveen Municipal 2021 Target Term Fund (NYSE: NHA) amounting to $0.1485 per share. The record date is set for February 23, 2021, with an ex-dividend date of February 22, 2021, and the payable date on February 26, 2021. The fund is scheduled to liquidate around March 1, 2021, aiming to return its original net asset value (NAV) of $9.85. As of February 11, 2021, the NAV was $9.86, but recent market conditions have increased risks associated with this objective.
